Methoxsalen

UVADEX 20 microgramos/ml SOLUCION PARA MODIFICACION DE LAS FRACCIONES SANGUINEAS

20 µg solución para modificación de las fracciones sanguíneasSpainMarketedAuthorised 14 Jan 2010

In other countries

The same active substances on other registers, the same brand first.

UvadexCanada · 20 MCG / ML · Solution · Therakos LLCSame brand
UvadexItaly · Soluzione per infusione · Therakos Europe LimitedSame brand
Uvadex 20 microgram/ml oplossing voor het modificeren van een bloedfractieNetherlands · Oplossing voor het modificeren van een bloedfractie · Therakos Europe LimitedSame brand
UvadexUnited States · 0.02MG/ML · injectable · Therakos DevelopmentSame brand
Ultra Mop Lotion 1%Canada · 1 % / % · Liquid · Canderm G.P.Same form
Metoxsalene S.A.L.F.Italy · Soluzione per la modifica di frazione ematica · S.A.L.F. SPA Laboratorio FarmacologicoSame form
Oxsoralen Cap 10MGCanada · 10 MG · Capsule · Valeant Canada LP / Valeant Canada S.E.C.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Methoxsalen

UVADEX 20 microgramos/ml SOLUCION PARA MODIFICACION DE LAS FRACCIONES SANGUINEAS

20 µg solución para modificación de las fracciones sanguíneasSpainMarketedAuthorised 14 Jan 2010

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Metoxsalene G.L. PharmaItaly · Soluzione iniettabile · G.L. Pharma GMBH

AnyNew Zealand · Lotn 1.2%

Neo Meladinine F.R Tab 10MGSaudi Arabia · Memphis Chemicals

Oxsoralen Caps 10MGSaudi Arabia · I.C.N.Pharmaceuticals

Oxsoralen LotionSaudi Arabia · I.C.N.Pharmaceuticals

MethoxsalenUnited States · 10MG · capsule · Ani Pharms

Oxsoralen-UltraUnited States · 10MG · capsule · Bausch

Packs

Pack	Code	Status
UVADEX 20 microgramos/ml SOLUCION PARA MODIFICACION DE LAS FRACCIONES SANGUINEAS, 12 viales de 10 ml	664505

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Methoxsalen
Strength: 20 µg
Dosage form: solución para modificación de las fracciones sanguíneas
Route: uso extracorporal
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 14 Jan 2010
Registration: 70858
Marketing authorisation holder: Therakos Europe Limited
Procedure: National, MRP or DCP
Supply: Uso Hospitalario

Methoxsalen · 20 microgramos/ml · solución para modificación de las fracciones sanguíneas

Spain

Metoxaleno S.A.L.F. 20 Microgramos/ML Solucion Para Modificacion de Las Fracciones SanguineasMethoxsalen · 20 microgramos/ml · solución para modificación de las fracciones sanguíneasSpain

OxsoralenMethoxsalen · 10 mg · cápsula duraSpainSuspended